Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia.

Saved in:
Bibliographic Details
Title: Development of novel tools for dissection of central versus peripheral dopamine D2-like receptor signaling in dysglycemia.
Authors: Bonifazi A; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Ellenberger M; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Farino ZJ; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Aslanoglou D; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Rais R; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pereira S; Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Physiology, University of Toronto, Toronto, ON, Canada., Mantilla-Rivas JO; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA., Boateng CA; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Eshleman AJ; Research Service, VA Portland Health Care System, Portland, Oregon, USA.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR, USA., Janowsky A; Research Service, VA Portland Health Care System, Portland, Oregon, USA.; Departments of Behavioral Neuroscience and Psychiatry, Oregon Health & Science University, Portland, OR, USA.; Methamphetamine Abuse Research Center, Oregon Health & Science University, Portland, OR, USA., Hahn MK; Centre for Addiction and Mental Health, Toronto, ON, Canada.; Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada.; Department of Pharmacology, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Banting & Best Diabetes Centre, Toronto, ON, Canada., Schwartz GJ; The Fleischer Institute for Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, NY, USA.; Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA., Slusher BS; Department of Neurology, Johns Hopkins Drug Discovery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Newman AH; Medicinal Chemistry Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Freyberg Z; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.; Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA, USA.; Lead Contact.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 24. Date of Electronic Publication: 2024 Feb 24.
Publication Type: Preprint; Journal Article
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2024.02.21.581451